fbpx Skip to main content

This study, published in Diabetes Research and Clinical Practice, explores how diabetes, multiple chronic conditions, and mortality rates are affected by racial disparities. The study sample included patients with type 2 diabetes mellitus who also had multiple chronic health conditions. A retrospective analysis was done on 443,932 beneficiaries of Medicare in Michigan who fulfilled the above criteria. Cox regression was used to predict mortality rates, and multinomial logistic regression was used to determine predictors of combinations of multiple chronic conditions.

The researchers concluded that race did influence mortality rates in patients with type 2 diabetes mellitus who had multiple chronic conditions. Black individuals and American Indian/Alaska Natives were found to have higher mortality rates in general, while no significant disparity in mortality rates was found for whites and Hispanics. Black patients exhibited an increased risk of various chronic condition combinations, while white, Hispanic, and Native American/Alaskan Native patients all exhibited a lower risk. 

The mortality disparities persisted even when the data were adjusted for chronic conditions. This finding suggests that racial disparities profoundly impact diabetes mortality rates in Black individuals and Native Americans [1].

Source:

[1] Clements, J. M., West, B. T., Yaker, Z., Lauinger, B., McCullers, D., Haubert, J., Tahboub, M. A., & Everett, G. J. (2020). Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race. Diabetes Research and Clinical Practice, 159, 107984. https://doi.org/10.1016/j.diabres.2019.107984

You May Also Like::  Lifestyle Interventions for Ethnic Groups With Type 2 Diabetes

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.

#dermtwitter
@AADmember

New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More